Is Beyond stock stuck in “Burgatory”?
Beyond Meat (BYND) says its Beyond Steak Filet is now sold in retail at Wegmans and H-E-B after a DTC launch. The company reported Q4 2025 net revenue of $61.6M (-19.7% YoY) and gross profit of $1.4M (2.3% margin); FY2025 net revenue fell to $275.5M (-15.6%). It also faces a Nasdaq delisting notice, a shareholder lawsuit, and a rebrand to Beyond the Plant Protein Co.
How this was made
The 30-second read
Why it matters
The retail debut is a tangible growth lever, but the company’s financial deterioration and Nasdaq deficiency notice create a near-term risk-management focus for traders.
Market read
Traders get a mixed catalyst set: a new retail distribution channel for a top-selling SKU alongside time-bound exchange compliance risk and weak profitability prints.
What to watch
The article doesn’t quantify retail order sizes, margins, or sell-through; delisting risk may already be priced, making the incremental impact of the retail rollout smaller than it appears.
Background
Beyond Meat is rebranded as Beyond and is trying to broaden beyond plant-based burgers/sausages into broader protein categories.
Ticker impact
Beyond Meat launched Beyond Steak Filet into Wegmans and H-E-B, while also facing a Nasdaq $1 bid-price delisting warning and ongoing losses.
Likely choppy trading: short-term relief on retail availability, but continued pressure from delisting risk and deteriorating margins.
The article pairs a concrete product distribution milestone with hard financial deterioration (2025 revenue/gross profit declines) and a time-bound Nasdaq compliance deadline (Aug 31, 2026).
Market effects
Highlights continued commercialization attempts in plant-based proteins despite weak category demand and margin compression.
US retail distribution expansion (Wegmans, H-E-B) may modestly improve near-term visibility with health-focused shoppers.
Limited direct global read-through; China operations were wound down per the impairment discussion.
Counterpoint
If retail velocity matches DTC momentum, the Steak Filet could become a margin-stabilizing hero product even amid broader category weakness.
Key entities
- public_companyBeyond Meat (Beyond the Plant Protein Company)
Subject of the article; launched Beyond Steak Filet in major US retailers and faces Nasdaq delisting risk plus ongoing losses.
- regulatorNasdaq Listing Qualifications Department
Issued a deficiency notice after BYND traded below the $1 minimum bid-price requirement for 30 consecutive business days.
- courtU.S. District Court for the Central District of California
Venue for the securities class action lawsuit referenced in the article.
